A study from the University of Oslo in Norway found that MRI scans may be able to identify a key brain change earlier than ...

We finally have more options for people with Alzheimer’s. But those options only matter if they reach patients in time.

Alzheimer’s disease is a devastating neurodegenerative disorder and the most common form of dementia. It’s marked by the ...

MRI scans can detect signs of the disease years earlier than PET scans, a recent study published in ‘Nature Neuroscience’ ...

A collaborative study led by researchers in Arizona found that a new blood test improves early detection of Alzheimer's ...

The pathology of Alzheimer's disease has an inflammatory component that is characterized by upregulation of proinflammatory cytokines, particularly in response to amyloid-β (Aβ). Using the APPPS1 ...

Alzheimer’s disease (AD) is a heterogeneous disorder with multiple etiologies. Harnessing the immune system by blocking the programmed cell death receptor (PD)-1 pathway in an amyloid beta mouse model ...

Medically reviewed by Smita Patel, DO Key Takeaways Anti-amyloid medications taken in early-stage Alzheimer’s may slow ...

The finding in human cerebrospinal fluid also raises the possibility of using meprin-β as an indicator of Alzheimer’s. This ...

The Alzheimer’s risk gene APOE4 may actively damage brain blood vessels and sabotage the cellular systems that remove harmful ...

A hormone best known for its role in reproduction may also help explain one of medicine’s mysteries: why women face a far higher risk of Alzheimer’s disease than men. Researchers are investigating ...

The latest approvals expand the population of people who could be tested for the memory disorder—but experts warn the tests aren't for everyone.